• Title/Summary/Keyword: oncologists

Search Result 68, Processing Time 0.024 seconds

Colorectal Cancer Screening in High-risk Populations: a Survey of Cognition among Medical Professionals in Jiangsu, China

  • Chen, Yao-Sheng;Xu, Song-Xin;Ding, Yan-Bing;Huang, Xin-En;Deng, Bin;Gao, Xue-Feng;Wu, Da-Cheng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.11
    • /
    • pp.6487-6491
    • /
    • 2013
  • To investigate the cognition of medical professionals when following screening guidelines for colorectal cancer (CRC) and barriers to CRC screening. Between February 2012 and December 2012, an anonymous survey with 19-questions based on several CRC screening guidelines was randomly administered to gastroenterologists, oncologists, general surgeons, and general practitioners in Jiangsu, a developed area in China where the incidence of CRC is relatively high. The average cognitive score was 26.4% among 924 respondents. Gastroenterologists and oncologists had higher scores compared with others (p<0.01 and p<0.01, respectively); doctor of medicine (M.D.) with or without doctor of philosophy (Ph.D.) or holders with bachelor of medical science (BMS) achieved higher scores than other lower degree holders (P<0.05). More importantly, doctors who finished CRC related education in the past year achieved higher scores than the others (p<0.001). The most commonly listed barriers to referring high-risk patients for CRC screening were "anxiety about colonoscopy without anesthesia", "lack of awareness of the current guidelines" and "lack of insurance reimbursement". Lack of cognition was detected among doctors when following CRC screening guidelines for high-risk populations. Educational programs should be recommended to improve their cognition and reduce barriers to CRC screening.

Developing Telephone Guidelines for Symptom Management of Cancer for Outpatients with Cancer after Chemotherapy (항암화학요법 후 퇴원한 암 환자의 증상관리를 위한 전화상담 가이드라인 개발)

  • Park, Ihn Sook;Kim, Eun Mi;Oh, Pil Ju;Kim, Soo Jin;Kim, Hye Jin;Kim, Bo Kyung;Hwang, Eun Kyung;Park, Se Rim;Lee, Mi Jeong
    • Journal of Korean Clinical Nursing Research
    • /
    • v.18 no.2
    • /
    • pp.317-328
    • /
    • 2012
  • Purpose: This study was done to provide oncology nurses systemic guidelines designed to perform telephone counseling in outpatient settings treating patients with chemotherapy. Methods: Symptoms which are frequently questioned were identified through case reports recorded by 4 clinical nurse specialists from January 4 to December 31. 2010. Fifteen clinical experts and two hemato-oncologists reviewed the developed draft. Their opinions were synthesized to arrive at consensus on the ideal guidelines. This process confirmed content validity. The two hemato-oncologists also verified the face validity. Results: The six symptoms which were most frequently asked about were identified through 4,644 case reports and concerned pain, fever, skin alteration, nausea/vomiting, stomatitis and diarrhea. Evidence-based telephone triage guidelines for the 6 major symptoms in patients receiving chemotherapy were developed. Conclusion: These guidelines will help oncology nurses from novice to expert incorporate evidence-based telenursing into their practice.

Targeting Multidrug Resistance with Small Molecules for Cancer Therapy

  • Xia, Yan;Lee, Kyeong
    • Biomolecules & Therapeutics
    • /
    • v.18 no.4
    • /
    • pp.375-385
    • /
    • 2010
  • Conventional cancer chemotherapy is seriously limited by tumor cells exhibiting multidrug resistance (MDR), which is caused by changes in the levels or activity of membrane transporters that mediate energy-dependent drug efflux and of proteins that affect drug metabolism and/or drug action. Cancer scientists and oncologists have worked together for some time to understand anticancer drug resistance and develop pharmacological strategies to overcome such resistance. Much focus has been on the reversal of the MDR phenotype by inhibition of ATP-binding cassette (ABC) drug transporters. ABC transporters are a family of transporter proteins that mediate drug resistance and low drug bioavailability by pumping various drugs out of cells at the expense of ATP hydrolysis. Many inhibitors of MDR transporters have been identified, and though some are currently undergoing clinical trials, none are in clinical use. Herein, we briefly review the status of MDR in human cancer, explore the pathways of MDR in chemotherapy, and outline recent advances in the design and development of MDR modulators.

Basics of particle therapy I: physics

  • Park, Seo-Hyun;Kang, Jin-Oh
    • Radiation Oncology Journal
    • /
    • v.29 no.3
    • /
    • pp.135-146
    • /
    • 2011
  • With the advance of modern radiation therapy technique, radiation dose conformation and dose distribution have improved dramatically. However, the progress does not completely fulfi ll the goal of cancer treatment such as improved local control or survival. The discordances with the clinical results are from the biophysical nature of photon, which is the main source of radiation therapy in current field, with the lower linear energy transfer to the target. As part of a natural progression, there recently has been a resurgence of interest in particle therapy, specifically using heavy charged particles, because these kinds of radiations serve theoretical advantages in both biological and physical aspects. The Korean government is to set up a heavy charged particle facility in Korea Institute of Radiological & Medical Sciences. This review introduces some of the elementary physics of the various particles for the sake of Korean radiation oncologists' interest.

A Study on Follow up of Survived Patients in Radiation Oncology Greater Area Database by Web Mail

  • Shimizu, Keiji;Harano, Masako;Harauchib, Hajime;Kou, Hiroko;Kumazaki, Yu;Ishibashi, Masatoshi;Numasaki, Hodaka;Yoshioka, Munenori;Inamura, Kiyonari
    • Proceedings of the Korean Society of Medical Physics Conference
    • /
    • 2002.09a
    • /
    • pp.133-135
    • /
    • 2002
  • We developed a system that can assist to automatically survey survived patients and to lighten the hard work imposed on radiation oncologists employing Radiation Oncology Greater Area Database (ROGAD) and Internet by web mail.

  • PDF

Review of National Institutes of Health NCI's Office of Cancer Complementary and Alternative Medicine Best Case Series Program (미국 국립보건원 국립암센터 암 보완대체의학 사무국에서 시행하고 있는 최상사례 프로그램에 대한 고찰)

  • Park, Il-Dong;Yoo, Hwa-Seung;Lee, Yeon-Weol;Cho, Chong-Kwan
    • Journal of Korean Traditional Oncology
    • /
    • v.10 no.1
    • /
    • pp.47-55
    • /
    • 2005
  • Objectives: The purpose is to advertise the protocol of Best Case Series Programme of National Cancer Institute of USA to korean oriental medical oncologists and researchers Method: We reviewed the submission packet of NCI and related Website and articles. Result and Conclusion: BCS programme is the first step to evaluate the efficacy of complementary and alternative treatment, and to launch the clinical research funded by NCI.

  • PDF

Basics of particle therapy II: relative biological effectiveness

  • Choi, Jin-Hyun;Kang, Jin-Oh
    • Radiation Oncology Journal
    • /
    • v.30 no.1
    • /
    • pp.1-13
    • /
    • 2012
  • In the previous review, the physical aspect of heavy particles, with a focus on the carbon beam was introduced. Particle beam therapy has many potential advantages for cancer treatment without increasing severe side effects in normal tissue, these kinds of radiation have different biologic characteristics and have advantages over using conventional photon beam radiation during treatment. The relative biological effectiveness (RBE) is used for many biological, clinical endpoints among different radiation types and is the only convenient way to transfer the clinical experience in radiotherapy with photons to another type of radiation therapy. However, the RBE varies dependent on the energy of the beam, the fractionation, cell types, oxygenation status, and the biological endpoint studied. Thus this review describes the concerns about RBE related to particle beam to increase interests of the Korean radiation oncologists' society.

Barriers to Early Palliative Care

  • Yoon, Seok-Joon
    • Journal of Hospice and Palliative Care
    • /
    • v.23 no.4
    • /
    • pp.252-255
    • /
    • 2020
  • This article aims to discuss the barriers hindering cancer patients from receiving early palliative care, which has been demonstrated to be more effective in improving quality of life and controlling symptoms. Specifically, there are barriers in four aspects of delivering early palliative care. First, the difficulty of starting discussions about early palliative care and the lack of adequate appointment time can impede communication between oncologists and patients and their family members. Second, determining the timing of referral and deciding upon and applying a standard for referral can be barriers in the process of referral from oncology to palliative care. Third, palliative care patients and their family members can face difficulties regarding in what format and by whom the services will be delivered. Fourth, biases, misinformation, and inaccurate beliefs can be barriers in the process of patients and their family members accepting care. In order to facilitate early palliative care, research and policy regarding these barriers are necessary, along with efforts made by medical staff.

Radiation Recall Myositis during Gemcitabine Chemotherapy (젬시타빈 항암치료 중 발생한 방사선 회상 근염)

  • Park, Jin Ho;Kim, Yoon;Yeo, Seung Mi;Hwang, Ji Hye
    • Clinical Pain
    • /
    • v.19 no.2
    • /
    • pp.106-110
    • /
    • 2020
  • Radiation recall is an uncommon phenomenon in which administration of a chemotherapy or another systemic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. Gemcitabine can induce an inflammatory reaction within an area of prior radiation. Radiation recall is known to medical oncologists, however only few cases have been reported in Korean journals, therefore physiatrist who diagnose and treat the treatment-related physical impairments of cancer patients must know about it. We emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of painful limb edema in a patient who has received cancer treatment.

Mesenteric Approach in Pancreatoduodenectomy

  • Akimasa Nakao
    • Journal of Digestive Cancer Research
    • /
    • v.4 no.2
    • /
    • pp.77-82
    • /
    • 2016
  • The 26th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) was held in Seoul, Korea from September 8 to 10, 2016. In this congress, I gave a State-of-the-Art Lecture II entitled "Mesenteric Approach in Pancreatoduodenectomy." The ideal surgery for pancreatic head cancer is isolated pancreatoduodenectomy, which involves en bloc resection using a non-touch isolation technique. My team has been developing isolated pancreatoduodenectomy for pancreatic cancer since 1981, when we developed an antithrombogenic bypass catheter for the portal vein. In this operation, the first and most important step is the use of a mesenteric approach instead of Kocher's maneuver. The mesenteric approach allows dissection from the non-cancer infiltrating side and determination of cancer-free margins and resectability, followed by systematic lymphadenectomy around the superior mesenteric artery. This approach enables early ligation of the inferior pancreatoduodenal artery and total mesopancreas excision. It is the ideal surgery for pancreatic head cancer from both oncological and surgical viewpoints. The precise surgical techniques of the mesenteric approach are herein described.

  • PDF